RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...
There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Donald Trump’s electoral victory has shaken the market, mostly in a good way. The S&P 500 gained 5% in the first two days ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback